Use of prescription medications associated with weight gain among US adults, 1999-2018: A nationally representative survey.

ABSTRACT:

Objective

This study aimed to evaluate trends in the use of obesogenic medications among adults.

Methods

Cross-sectional data on adults aged ≥20 years are from the 1999 to 2018 National Health and Nutrition Examination Survey (n = 52,340). Obesogenic medications were defined according to the 2015 Endocrine Society guidelines on the pharmacological management of obesity. Weight status was categorized according to BMI. Trends in prior 30-day use were evaluated.

Results

In NHANES 2017-2018, 20.3% of US adults used an obesogenic medication. Beta-blockers (9.8%) and antidiabetics (5.7%) were the most common; antipsychotics (1.0%) were the least common. Most common indications were disorders of glucose metabolism, hypertension, neuralgia or neuritis, heart disease, and musc

SUBMITTER: Hales CM 

PROVIDER: S-EPMC8842491 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature